Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Abstract
Transfection of embryo fibroblasts by a human ras oncogene does not convert them into tumour cells unless the fibroblasts are established and immortalized before transfection. The embryo fibroblasts become tumorigenic if a second oncogene such as a viral or cellular myc gene or the gene for the polyoma large-T antigen is introduced together with the ras gene.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, transformation of primary cells by ras requires either a cooperating oncogene or the inactivation of tumor suppressors such as p53 or p16.”
From Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a (1997) · cites this paper as Land et al. 1983
In the citing paper
“ras cooperates, however, with certain other oncogenic alterations to transform primary rodent cells (Land et al. 1983; Ruley 1983), including overexpression of c-Myc, dominant negative p53, D-type cyclins, and Cdc25A and -B, and loss of p53, p16, or IRF-1”
From Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a (1997) · cites this paper as Land et al. 1983
In the citing paper
“In that setting, dysfunctional telomeres induced a strong cellular senescence phenotype in the emerging lymphomas resulting in potent suppression of lymphomagenesis.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [93]
Citations
Cites
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451
Dalla-Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R. C., & Croce, C. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7824 · Cited by 1,773
Mutation selection and the natural history of cancer
Cairns, J. (1975) · Nature · doi:10.1038/255197a0 · Cited by 1,582
Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis
Hayward, W. S., Neel, B. G., & Astrin, S. M. (1981) · Nature · doi:10.1038/290475a0 · Cited by 1,567
Taub, R., Kirsch, I., Morton, C., Lenoir, G., Swan, D., Tronick, S., Aaronson, S., & Leder, P. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7837 · Cited by 1,422
Mechanism of activation of a human oncogene
Tabin, C. J., Bradley, S. M., Bargmann, C. I., Weinberg, R. A., Papageorge, A. G., Scolnick, E. M., Dhar, R., Lowy, D. R., & Chang, E. H. (1982) · Nature · doi:10.1038/300143a0 · Cited by 1,393
Self-citationRuley, H. E. (1983) · Nature · doi:10.1038/304602a0 · Cited by 1,248
Mulligan, R. C., & Berg, P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2072 · Cited by 982
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 944
Self-citationDer, C. J., Krontiris, T. G., & Cooper, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3637 · Cited by 800
Research works printed but not linked: 9
- Berenblum, I. & Shubik, P. Br. J. Cancer 1, 388 (1947).
- Emmelot, P. & Scherer, E. Cancer Res. 37, 1702–1708 (1977).
- Crawford, B. D., Barrett, J. C. & Ts'o, P. O. P. Molec. cell. Biol. 3, 931–945 (1983). · doi:10.1128/mcb.3.5.931
- Murray, M. J. et al. Cell (in the press).
- Aaronson, S. A. & Todaro, G. J. J. Cell Biol. 72, 141–148 (1968).
- Perucho, M., Hanahan, D. & Wigler, M. Cell 22, 309–317 (1980). · DOI · Paper page
- Beard, J. W. in Viral Oncology (ed. Klein, G.) 55–88 (Raven, New York, 1980).
- Adams, J. M., Gerondakis, S., Webb, E., Corcoran, L. & Cory, S. Proc. natn. Acad. Sci. U.S.A. (in the press).
- Gross, L. Oncogenic viruses, 931 (Pergamon, Oxford, 1970).
Cited by
Items 501–600 of 1,010
Large T antigens of simian virus 40 and polyomavirus efficiently establish primary fibroblasts
Jat, P. S., & Sharp, P. A. (1986) · Journal of Virology · doi:10.1128/jvi.59.3.746-750.1986 · Cited by 125
“Cells were prepared for injection as described previously (16).”
MethodCell cycle: Routine role for Ras
Downward, J. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00116-3 · Cited by 147
“By itself, Ras causes growth arrest in these cells [17–19].”
Viral transduction of c-myc gene in naturally occurring feline leukaemias
Mullins, J. I., Brody, D. S., Binari, R. C., & Cotter, S. M. (1984) · Nature · doi:10.1038/308856a0 · Cited by 125
Mukherjee, B., Morgenbesser, S. D., & DePinho, R. A. (1992) · Genes & Development · doi:10.1101/gad.6.8.1480 · Cited by 127
Expression and Activity of L-Myc in Normal Mouse Development
Hatton, K. S., Mahon, K., Chin, L., Chiu, F.-C., Lee, H.-W., Peng, D., Morgenbesser, S. D., Horner, J., & Depinho, R. A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1794 · Cited by 118
“On the biological level, all three myc family genes can cooperate with a mutant H-RAS gene to transform early-passage rat embryo fibroblasts (17, 35, 63, 73) and can generate tumors when overexpressed in transgenic mice (for a review, see reference 43).”
BackgroundMourant, J. R., Hielscher, A. H., Eick, A. A., Johnson, T. M., & Freyer, J. P. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981225)84:6<344::aid-cncr5>3.0.co;2-r · Cited by 124
Alternative Forms of Max as Enhancers or Suppressors of Myc-Ras Cotransformation
Mäkelä, T. P., Koskinen, P. J., Västrik, I., & Alitalo, K. K. (1992) · Science · doi:10.1126/science.256.5055.373 · Cited by 125
Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms
Elliott, K., Sakamuro, D., Basu, A., Du, W., Wunner, W. H., Staller, P., Gaubatz, S., Zhang, H., Prochownik, E. V., Eilers, M., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202670 · Cited by 126
“…1997); p1A/neo contains the 5' end of the adenovirus type 5 genome including the E1A region (Maruyama et al., 1987); LTR p53ts encodes a temperature-sensitive dominant inhibitory mutant of murine p53 (Michalovitz et al., 1990); and pT22 contains an activated Hras gene (Land et al., 1983).”
BackgroundMethodSuda, Y., Aizawa, S., Hirai, S.-I., Inoue, T., Furuta, Y., Suzuki, M., Hirohashi, S., & Ikawa, Y. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02751.x · Cited by 123
Simon, M. C., Kitchener, K., Kao, H., Hickey, E. D., Weber, L. E., Voellmy, R. W., Heintz, N., & Nevins, J. R. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2884-2890.1987 · Cited by 123
“In combination with E1B or other oncogenes, ElA expression can transform cells to an oncogenic state (9, 23, 43, 49).”
BackgroundOncogenes and human cancer: cause or consequence?
Barbacid, M. (1986) · Carcinogenesis · doi:10.1093/carcin/7.7.1037 · Cited by 123
Cellular senescence: Neither irreversible nor reversible
Reimann, M., Lee, S., & Schmitt, C. A. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20232136 · Cited by 136
“(cid:129) Myc, cooperation with OIS-enforcing oncogenic Ras (Hydbring et al., 2010; Land et al., 1983; Ruggero et al., 2004).”
BackgroundFrom Adult Stem Cells to Cancer Stem Cells
Trosko, J. E. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1386.018 · Cited by 134
Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis.
Thulasi, R., Harbour, D. V., & Thompson, E. B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46845-1 · Cited by 122
Ayusawa, D., Shimizu, K., Koyama, H., Kaneda, S., Takeishi, K., & Seno, T. (1986) · Journal of Molecular Biology · doi:10.1016/0022-2836(86)90241-x · Cited by 122
Kao, H., Capasso, O., Heintz, N., & Nevins, J. R. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.4.628 · Cited by 122
Beard, B. C., Dickerson, D., Beebe, K., Gooch, C., Fletcher, J., Okbinoglu, T., Miller, D. G., Jacobs, M. A., Kaul, R., Kiem, H.-P., et al. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300159 · Cited by 118
Gas2, a growth arrest-specific protein, is a component of the microfilament network system
Brancolini, C., Bottega, S., & Schneider, C. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.117.6.1251 · Cited by 121
“Cellular transformation, on the other hand, leads to alterations in cell shape, cellular metabolism, gene expression, and growth control and, as a prerogative, is defective in reaching growth arrest ( 17 ).”
BackgroundHuman Proto-Oncogene N-myc Encodes Nuclear Proteins That Bind DNA
Ramsay, G. M., Stanton, L. W., Schwab, M., & Bishop, J. M. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.12.4450 · Cited by 121
Khazaie, K., Dull, T. J., Graf, T., Schlessinger, J., Ullrich, A., Beug, H., & Vennström, B. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03171.x · Cited by 131
Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility
Xia, M., & Land, H. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1208 · Cited by 127
Self-citationBiological activities of v-myc and rearranged c-myc oncogenes in rat fibroblast cells in culture.
Mougneau, E., Lemieux, L., Rassoulzadegan, M., & Cuzin, F. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.18.5758 · Cited by 120
For Better or Worse? Telomerase Inhibition and Cancer
de Lange, T., & Jacks, T. (1999) · Cell · doi:10.1016/s0092-8674(00)81955-8 · Cited by 119
HRAS and the Costello syndrome
Rauen, K. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00743.x · Cited by 110
“Mutations in co-operating oncogenes or tumor suppressor genes are required for transformation to occur (40, 41).”
BackgroundRoles of UDP-Glucuronosyltransferases in Chemical Carcinogenesi
Bock, K. W. (1991) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239109081125 · Cited by 125
Glaichenhaus, N., Léopold, P., & Cuzin, F. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04355.x · Cited by 119
Transgenic Mice And Oncogenesis
Cory, S. (1988) · Annual Review of Immunology · doi:10.1146/annurev.immunol.6.1.25 · Cited by 123
The human myc gene family: structure and activity of L-myc and an L-myc pseudogene.Preprint
DePinho, R. A., Hatton, K. S., Tesfaye, A., Yancopoulos, G. D., & Alt, F. W. (1987) · Genes & Development · doi:10.1101/gad.1.10.1311 · Cited by 119
Ignored Hallmarks of Carcinogenesis: Stem Cells and Cell‐Cell Communication
Trosko, J. E., CHANG, C., Upham, B. L., & TAI, M. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1322.023 · Cited by 118
Warner, J. K., Wang, J. C. Y., Takenaka, K., Doulatov, S. R., McKenzie, J. L., Harrington, L. A., & Dick, J. E. (2005) · Leukemia · doi:10.1038/sj.leu.2403917 · Cited by 137
Ruf, I. K., Rhyne, P., Yang, C., Cleveland, J. L., & Sample, J. T. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.10223-10228.2000 · Cited by 138
“Although deregulated expression of c-MYC is clearly a primary contributing factor in the development of BL, c-MYC overexpression itself is insufficient for the transformation of primary cells (30, 31), due to the activation of apoptotic pathways, particularly under growth-limiting conditions (2, 12).”
BackgroundAl-Mulla, F., Keith, W. N., Pickford, I. R., Going, J. J., & Birnie, G. D. (1999) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199904)24:4<306::aid-gcc3>3.0.co;2-5 · Cited by 133
Spreading of non-transformed and transformed cells
Vasiliev, J. M. (1984) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(84)90006-4 · Cited by 128
Micromanaging aerobic respiration and glycolysis in cancer cells
Orang, A. V., Petersen, J., McKinnon, R. A., & Michael, M. Z. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.01.014 · Cited by 115
“miR-509 EGFR, MDM2 Tongue Squamous Cell Carcinoma, Cervical Cancer, Hepatocellular Carcinoma, Prostate Cancer S [239,240], [355]”
BackgroundNeoplastic transformation by the human gene N-myc.
Small, M. B., Hay, N., Schwab, M., & Bishop, J. M. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.5.1638 · Cited by 117
Towards an understanding of the malignant transformation of diploid human fibroblasts
McCormick, J. J., & Maher, V. M. (1988) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(88)90209-6 · Cited by 120
Figge, J., Webster, T., Smith, T. F., & Paucha, E. (1988) · Journal of Virology · doi:10.1128/jvi.62.5.1814-1818.1988 · Cited by 120
“Similarly, polyomavirus large T was not detected by our descriptor, though it is known to be active in the ras cotransformation assay (17, 28).”
BackgroundCrook, T., Storey, A., Almond, N., Osborn, K., & Crawford, L. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.8820 · Cited by 118
Dissociation of transforming and trans-activation functions for bovine papillomavirus type 1
Yang, Y., Spalholz, B. A., Rabson, M. S., & Howley, P. M. (1985) · Nature · doi:10.1038/318575a0 · Cited by 117
Liao, D. J., Thakur, A. B., Wu, J., Biliran, H., & Sarkar, F. H. (2007) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v13.i2.10 · Cited by 125
Polyoma virus middle T antigen and its role in identifying cancer-related molecules
Dilworth, S. M. (2002) · Nature reviews. Cancer · doi:10.1038/nrc946 · Cited by 116
“These results formed the basis for the 'cooperating oncogene' hypothesis, as described in 1983 in the two influential papers by Hartmut Land and Bob Weinber”
ResultChemical Carcinogens: A Review of the Science and Its Associated Principles
(1986) · Environmental Health Perspectives · doi:10.1289/ehp.67-1474412 · Cited by 138
Oncogene activation and tumor progression
Klein, G., & Klein, E. (1984) · Carcinogenesis · doi:10.1093/carcin/5.4.429 · Cited by 116
trans Activation of the Simian Virus 40 Late Transcription Unit by T-Antigen
Brady, J. N., & Khoury, G. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.6.1391 · Cited by 122
Homologous cell-derived oncogenes in avian carcinoma virus MH2 and murine sarcoma virus 3611
Jansen, H. W., Lurz, R., Bister, K., Bonner, T. I., Mark, G. E., & Rapp, U. R. (1984) · Nature · doi:10.1038/307281a0 · Cited by 115
Characterization of human uroepithelial cells immortalized in vitro by simian virus 40.
Christian, B. J., Loretz, L. J., Oberley, T. D., & Reznikoff, C. A. (1987) · PubMed · Cited by 114
Molecular Genetics and Pathogenesis of Autosomal Dominant Polycystic Kidney Disease
Arnaout, M. A. (2001) · Annual Review of Medicine · doi:10.1146/annurev.med.52.1.93 · Cited by 125
ATM Couples Replication Stress and Metabolic Reprogramming during Cellular Senescence
Aird, K. M., Worth, A. J., Snyder, N. W., Lee, J. V., Sivanand, S., Liu, Q., Blair, I. A., Wellen, K. E., & Zhang, R. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.014 · Cited by 113
“c-MYC is a known regulator of RAS-induced senescence (Land et al., 1983; Sinn et al., 1987).”
Monsalve, M., & Olmos, Y. (2011) · Current Drug Targets · doi:10.2174/138945011796150307 · Cited by 124
“AKT-mediated phosphorylation of FOXO proteins is the critical PI3K signaling component that substitutes for oncogenic Ras in Mycinduced proliferation and focus formation in vitro [381, 382].”
BackgroundNoonan, Costello and cardio–facio–cutaneous syndromes: dysregulation of the Ras–MAPK pathway
Tidyman, W. E., & Rauen, K. A. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000902 · Cited by 110
Association of K-ras mutations with p16 methylation in human colon cancer
Guan, R. J., Fu, Y., Holt, P. R., & Pardee, A. B. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70009-0 · Cited by 151
Greene, J. M., Larin, Z., Taylor, I., Prentice, H. L., Gwinn, K. A., & Kingston, R. E. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.10.3646-3655.1987 · Cited by 117
“These oncogenes also are capable of efficiently immortalizing normal fibroblasts (20, 29, 39-42).”
BackgroundOncogene Amplification in Squamous Cell Carcinoma of the Oral Cavity
Saranath, D., Panchal, R. G., Nair, R., Mehta, A. R., Sanghavi, V., Sümegi, J., Klein, G., & Deo, M. G. (1989) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1989.tb02332.x · Cited by 113
Weller, M., Constam, D. B., Malipiero, U., & Fontana, A. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240608 · Cited by 113
Rapp, U. R., Cleveland, J. L., Fredrickson, T. N., Holmes, K. L., Morse, H. C., Jansen, H. W., Patschinsky, T., & Bister, K. (1985) · Journal of Virology · doi:10.1128/jvi.55.1.23-33.1985 · Cited by 121
“to the complementation observed between oncogenes for transformation of primary fibroblasts in vitro (25), synergism between v-rafand v-myc in vivo appears restricted to cells of the hematopoietic system and endodermal epithelium.”
BackgroundMultistage carcinogenesis involves multiple genes and multiple mechanisms
Weinstein, I. B., Gattoni‐Celli, S., Kirschmeier, P. T., Lambert, M. E., Hsiao, W. L. W., Backer, J. M., & Jeffrey, A. M. (1984) · Journal of Cellular Physiology · doi:10.1002/jcp.1041210416 · Cited by 113
Expression of the c-myb oncogene in human small cell lung carcinoma.
Griffin, C. A., & Baylin, S. B. (1985) · PubMed · Cited by 114
Mitogens and Oncogenes Can Block the Induction of Specific Voltage-Gated Ion Channels
Caffrey, J. M., Brown, A. M., & Schneider, M. D. (1987) · Science · doi:10.1126/science.2437651 · Cited by 112
Melki, R., & Cowan, N. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.2895 · Cited by 111
Epstein-Barr virus suspension cell assay using in situ hybridization and flow cytometry
Crouch, J. Y., Leitenberg, D., Smith, B. R., & Howe, J. G. (1997) · Cytometry · doi:10.1002/(sici)1097-0320(19970901)29:1<34::aid-cyto3>3.0.co;2-d · Cited by 25
The c-Ha-ras oncogene and a tumor promoter activate the polyoma virus enhancer
Wasylyk, C., Imler, J., Pérez-Mutul, J., & Wasylyk, B. (1987) · Cell · doi:10.1016/0092-8674(87)90203-0 · Cited by 111
Facchini, L. M., Chen, S., Marhin, W. W., Lear, J. N., & Penn, L. Z. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.100 · Cited by 106
“The human Myc protein domains required for suppression of the AdMLP localize to the MbII domain at amino acids 120 to 140 and to amino acids 410 to 439 (57), whereas for the cyclin D1 promoter, amino acids 92 to 104 and 370 to 412 are involved (78).”
BackgroundMetabolic Imaging in Multicellular Spheroids of Oncogene-transfected Fibroblasts
Walenta, S., Doetsch, J., Mueller-Klieser, W., & Kunz-Schughart, L. A. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004800409 · Cited by 107
“In 1996, the classical two-step carcinogenesis model of myc / ras -co-transfected rat embryo fibroblasts (REFs) proposed by Land et al. (1983) and Weinberg (1989) was established and characterized as a spheroid culture Correspondence to: Dr. L.A. Kunz–Schughart, Institute of Pathology, University…”
MethodPre-cancerous steps in carcinogenesis Their physicological adaptive nature
Farber, E. (1984) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(83)90002-1 · Cited by 110
Thierry, F., Heard, J. M., Dartmann, K., & Yaniv, M. (1987) · Journal of Virology · doi:10.1128/jvi.61.1.134-142.1987 · Cited by 109
“We have shown here that expression from the HPV18 sequence is modulated by viral early antigens which are associated with regulation of viral transcription as well as with cellular immortalization (20, 25, 28).”
BackgroundExpression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB
Aasland, R., Lillehaug, J., Male, R., Jøsendal, O., Varhaug, J. E., & Kleppe, K. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.82 · Cited by 112
“The anaplastic carcinoma may be an example of a tumour in which the action of these two oncogenes contributes to the transformation in a cooperative manner (Land et al., 1983 ).”
BackgroundWang, C., Lisanti, M. P., & Liao, D. J. (2011) · Cell Cycle · doi:10.4161/cc.10.1.14449 · Cited by 109
“, can grow indefinitely in culture, (2) the cell can efficiently form colonies in agar, (3) the cell can develop tumor in immunodeficient mice and (4) the xenograft or orthotopic tumor in the mouse shows malignant histology to exclude a pseudo-tumor or a benign tumor.”
BackgroundSecombe, J., Pierce, S. B., & Eisenman, R. N. (2004) · Cell · doi:10.1016/s0092-8674(04)00336-8 · Cited by 127
Genetic dissection of histone deacetylase requirement in tumor cells
Haberland, M., Johnson, A., Mokalled, M. H., Montgomery, R. L., & Olson, E. N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903139106 · Cited by 109
Gelmann, E. P., Psallidopoulos, M. C., Papas, T. S., & Favera, R. D. (1983) · Nature · doi:10.1038/306799a0 · Cited by 109
A growth-related mRNA in cultured mouse cells encodes a placental calcium binding protein
Jackson‐Grusby, L., Swiergiel, J. J., & Linzer, D. I. H. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.16.6677 · Cited by 113
Lee, W. M., Schwab, M., Westaway, D., & Varmus, H. E. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.12.3345 · Cited by 109
The p53 cellular tumor antigen: gene structure, expression and protein properties
Oren, M. (1985) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(85)90015-0 · Cited by 109
The Poly(A) Tail Inhibits the Assembly of a 3′-to-5′ Exonuclease in an In Vitro RNA Stability System
Ford, L. P., Bagga, P. S., & Wilusz, J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.398 · Cited by 108
Expression of the metastatic phenotype in cells transfected with human metastatic tumor DNA.
Bernstein, S. C., & Weinberg, R. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.6.1726 · Cited by 108
Self-citationCellular transforming genes and oncogenesis
Cooper, G. M., & Lane, M. (1984) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(84)90017-9 · Cited by 122
Betsholtz, C., Heldin, C., Nistér, M., Ek, B., Wasteson, Å., & Westermark, B. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(83)91557-7 · Cited by 108
Role of Ras/Raf/MEK/ERK signaling in physiological hematopoiesis and leukemia development
Chung, E., & Kondo, M. (2010) · Immunologic Research · doi:10.1007/s12026-010-8187-5 · Cited by 114
Redox regulation of renal DNA synthesis, transforming growth factor-β1 and collagen gene expression
Nath, K. A., Grande, J. P., Croatt, A. J., Haugen, J. D., Kim, Y., & Rosenberg, M. E. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00778.x · Cited by 111
“Besides glutathione peroxidase and catalase, other cDNA probes utilized in this study included mouse c-myc [34], rat histone H2b [35], rat collagens a1(I) and a1(III) [36], collagen a1(IV) [37] and TGF-b1 [38].”
MethodCell-type-specific pattern of myc protooncogene expression in developing human embryos.
Pfeifer‐Ohlsson, S., Rydnert, J., Goustin, A. S., Larsson, E., Betsholtz, C., & OHLSSON, R. I. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.15.5050 · Cited by 111
Sequencing the erb A Gene of Avian Erythroblastosis Virus Reveals a New Type of Oncogene
Debuire, B., Henry, C., Bernissa, M., Biserte, G., Claverie, J., Saule, S., Martin, P., & Stéhelin, D. (1984) · Science · doi:10.1126/science.6328658 · Cited by 113
The PKB/FOXO switch in aging and cancer
Kloet, D. E. A., & Burgering, B. M. T. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.04.003 · Cited by 111
SIRT3-Mediated Dimerization of IDH2 Directs Cancer Cell Metabolism and Tumor Growth
Zou, X., Zhu, Y., Park, S., Liu, G., O’Brien, J., Jiang, H., & Gius, D. R. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2393 · Cited by 115
“12 Based on the results above, it seemed reasonable to determine if enforced expression of IDH2 (de-Ac-mimic) and/or IDH2 (Ac-mimic) would alter the transformative properties of immortalized NIH3T3 cells infected with virus expressing Myc or oncogenic Ras (Ras) (17, 18).”
Cancer stem cells: the lessons from pre‐cancerous stem cells
Gao, J. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00170.x · Cited by 107
“Genetic studies have revealed that a malignancy such as human colorectal cancer, a classical genetic model of tumourigenesis [4], undergoes multi-step epigenetic alterations and oncogenic genetic mutations [4, 59, 76–78].”
Shichiri, M., Hanson, K. D., & Sedivy, J. M. (1993) · PubMed · Cited by 121
Kim, Y., Christman, J., Fleet, J., Cravo, M. L., Salomon, R., Smith, D. E., Ordovás, J. M., Selhub, J., & Mason, J. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.5.1083 · Cited by 106
“second and third exons of c-myc (45, 46 ) that has been sub-”
BackgroundThe oncogenic potential of deregulated homeobox genes.
Maulbecker, C. C., & Gruss, P. (1993) · PubMed · Cited by 106
Kerr, L. D., Olashaw, N., & Matrisian, L. M. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37489-1 · Cited by 121
Tumurigenesis by slow-transforming retroviruses—an update
van Lohuizen, M., & Berns, A. J. M. (1990) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(90)90005-l · Cited by 126
Petrenko, O., Zaika, A. I., & Moll, U. M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5540-5555.2003 · Cited by 123
Yarden, Y., & Weinberg, R. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.9.3179 · Cited by 105
Self-citationTransforming ras oncogenes and multistage carcinogenesis
Balmain, A. (1985) · British Journal of Cancer · doi:10.1038/bjc.1985.1 · Cited by 105
Schreiber, F. S., Deramaudt, T. B., Brunner, T. B., Boretti, M. I., Gooch, K. J., Stoffers, D. A., Bernhard, E. J., & Rustgi, A. K. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.058 · Cited by 108
Escape from premature senescence is not sufficient for oncogenic transformation by Ras
Peeper, D. S., Dannenberg, J., Douma, S., Riele, H. T., & Bernards, R. (2001) · Nature Cell Biology · doi:10.1038/35055110 · Cited by 112
Regulation of Btk by Src Family Tyrosine Kinases
Afar, D. E. H., Park, H., Howell, B. W., Rawlings, D. J., Cooper, J., & Witte, O. N. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3465 · Cited by 104
“This increase in transformation activity is comparable to the synergy observed with coexpression of ras and myc (21) or of the bcr-abl tyrosine kinase oncogene and myc (26).”
A Two-Mutation Model for Radon-Induced Lung Tumors in Rats
Moolgavkar, S. H., Cross, F. T., Luebeck, E. G., & Dagle, G. E. (1990) · Radiation Research · doi:10.2307/3577560 · Cited by 112
Johnson, B. E., Battey, J. F., Linnoila, I. R., Becker, K. L., Makuch, R., Snider, R. H., Carney, D. N., & Minna, J. D. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112604 · Cited by 104
Yuspa, S. H., Kilkenny, A., Stanley, J. R., & Lichti, U. F. (1985) · Nature · doi:10.1038/314459a0 · Cited by 104
Cowie, A., & Kamen, R. (1984) · Journal of Virology · doi:10.1128/jvi.52.3.750-760.1984 · Cited by 104
“This establishment function of the large T antigen can complement the activity of cellular or viral oncogenes in the tumorgenic conversion of mortal rodent cells (29, 45).”
BackgroundA transforming function of the BARF1 gene encoded by Epstein‐Barr virus.
Wei, M., & Ooka, T. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08438.x · Cited by 112
Metadata
- Authors
- Land, H., Parada, L. F., & Weinberg, R. A.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Venue
- Nature
- Published
- 1983-08
- Volume
- 304
- Issue
- 5927
- Pages
- 596-602
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1989009382
- Cited by
- 2,804
- References
- 56
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 22 · 2023: 15 · 2022: 17 · 2021: 24 · 2020: 22 · 2019: 36 · 2018: 17 · 2017: 23 · 2016: 24 · 2015: 39 · 2014: 27 · 2013: 30 · 2012: 37
- FWCI
- 96.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Keywords
- embryonic fibroblasts, oncogene cooperation, oncogenic Ras, MYC gene, polyomavirus large T antigen, cell immortalization, transfection
- MeSH terms
- Animals, Antigens, Viral, Antigens, Viral, Tumor, Cell Line, Cell Transformation, Viral, Cells, Cultured, Fibroblasts, Gene Expression Regulation, Genes, Viral, Genetic Complementation Test, Oncogenes, Phenotype, Polyomavirus, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.